PHYSICIANS: ProACT™ For Men

ProACT™ Therapy is a minimally invasive urological implant designed to treat male patients who have stress urinary incontinence following radical prostatectomy for prostate cancer or transurethral resection of the prostate (TURP) for benign prostatic hyperplasia (BPH).
Important Safety Information About ACT
Click here for the ProACT™ Fluoroscopy Video (7 MB)
Incidence of Urinary Incontinence in Male Patients
Recurrent stress incontinence is often a disturbing complication following this surgical removal of the prostate. A recent study revealed that 18 months after radical prostatectomy, 8.4% of patients were incontinent (frequent urinary leakage or no urinary control) and 59.9% of men were impotent.2
Prevalence estimates of post-prostatectomy stress incontinence vary from 6-69%, depending on the method used to measure incontinence and surgeon skill. Retrospective physician studies typically report lower incontinence rates than patient reported outcomes.3
Adjustable Continence Therapy (ProACT™)
ProACT Therapy offers an effective first-line treatment option for post-prostatectomy incontinence before invasive surgical consideration or implant of an Artificial Urinary Sphincter (A.U.S.) or adjustable sling. Median time to regain continence after radical prostatectomy is ~3 months;4 if a patient still leaks after six months, it is worthwhile to consider ProACT Therapy.
Benefits of ProACT Therapy include:
The potential risks with the ProACT implant procedure are similar to those for other surgical treatments for stress urinary incontinence. These include, but are not limited to, the following:
If an infection occurs at the implant site, it can be treated with antibiotics. If a more serious side effect occurs (e.g., perforation, migration), ProACT can be completely removed.
The ProACT Device for Treatment of Recurrent Stress Incontinence Resulting from Intrinsic Sphincter Deficiency
The ProACT Device consists of two post-operatively adjustable balloon implants placed via perineal approach bilaterally in a periurethral position at the bladder neck or at the apex of the prostatic remnant. The implant procedure is minimally invasive and may be performed with general or spinal anesthesia.
Titanium ports [Figure 1], attached via discrete tubing to each balloon, are placed in the scrotum, allowing for subcutaneous, post-operative volume adjustment. Increasing the balloon volumes will increase coaptation of the urethra and lift the bladder neck, which may improve continence. Adjustments can continue to be made to best meet the needs of the patient.
Figure 1. Cross-Section of Implantable Balloon

ProACT is available in two sizes (12 cm and 14 cm) to fit the individual needs of your patients.
Urologi Inc. has developed a set of dedicated implant tools for the Adjustable Continence Therapy. The set consists of a u-channel sheath, a blunt and a sharp trocar and a tissue expanding device (TED) [Figure 2].
Figure 2. Dedicated Implant Tools

Clinical Data Regarding Patients with Post-prostatectomy Stress Incontinence
[insert picture ProAct –patients-prostatectomy]
In a clinical study, ProACT Therapy produced “durable outcomes equivalent or better than other minimally invasive treatments for incontinence after prostatectomy.” After a mean follow-up of 13 months, 67% of men were dry and 92% were significantly improved.5
Participants also reported using fewer pads [Figure 3] and a lower Stamey Score [Figure 4] after ProACT Device implant. Complications experienced were mostly minor and decreased with increasing experience. Complications experienced include perforation, retention, balloon rupture, migration, erosion and explant.5
Figure 3. Pad Usage After ProACT Implant

Figure 4. Improvement in Stamey Score After ProACT Implant

To order literature on Adjustable Continence Therapy, please feel free to contact us.